EPO Knocks Down Trio of Geron Patent Claims
In another blow to Geron Corp., the European Patent Office has ruled in favor of Danish pharmaceutical giant Pharmexa A/S and invalidated three claims of the U.S. biotechnology company's European patent...To view the full article, register now.
Already a subscriber? Click here to view full article